This study offers a comprehensive analysis of the most relevant AML surface antigenic markers —CD123, CD33, ADGRE2, CLL-1, TIM-3, CD70, among others— along with their expression patterns across key cell types, including leukemic blasts, leukemic stem cells, hematopoietic stem cells and progenitors, adult blood cells, and other tissues. This evidence concerns the gene IL3RA and acute myeloid leukemia.